I know I am grasping at straws here. It is basically all I

New Post Public Reply Private Reply Replies (0) Message Board
hylander drexel #36455
852
I know I am grasping at straws here. It is basically all I have. I am still ticked off at what happened with Generex and what Management did.

We can blame Joe, however I still think and maybe I am wrong, but everyone at Generex knew what was going on. All the management abandoned the ship and went back to their old companies without even a notice to any of the shareholders and left us all in the dark while they knew what was going on. They had a fallback.

Here, we have stock that was given to us in a company that was purchased by another company. That 'should' count for something. Should being the key word here.

We were also told that company had 5 billion dollars behind it as well. So, not sure if that was true or not. We were told a lot of things by Joe and those at Generex. If that is true, then NuGenerex has no reason not to succeed to some point at least in the short term. When you look at their web site though, they don't seem in any hurry to make the company a priority. That is a concern, which seems like Generex all over again......

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Zhihu Inc. Announces Annual Report Submission for 2024

Updated Category News Views 157

Zhihu Inc. Submits Annual Report for 2024 BEIJING — Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a front-runner in China's online content community ecosystem, is pleased to announce the submission of its annual report on Form 20-F for the fiscal year observed until December 31, 2024. This report was officially filed with the Securities and...

Continue Reading
Debbie Wasserman Schultz's Strategic Trades in Key Companies

Updated Category News Views 1462

Congresswoman Debbie Wasserman Schultz's Recent Stock Transactions In the latest congressional trading report, Congresswoman Debbie Wasserman Schultz, a prominent figure, has made noteworthy moves in the stock market. Her recent trades reveal a strategic approach to investing in various sectors, particularly the healthcare and mining industries. Investments in Baxter...

Continue Reading
LifeMD, Inc. Securities Class Action: How to Join the Fight

Updated Category News Views 166

LifeMD, Inc. Securities Class Action Overview The Rosen Law Firm, renowned for its expertise in investor rights, is encouraging investors of LifeMD, Inc. to act quickly in a significant securities class action. This class action is a result of allegations of misleading statements made by the company, and the clock is ticking toward important legal deadlines. Why Act Now?...

Continue Reading
SPX FLOW's Innovation Shines Again with Sustainable Award

Updated Category News Views 93

SPX FLOW Achieves Recognition for Sustainable Innovation SPX FLOW, a renowned leader in process solutions, has once again showcased its commitment to sustainability by winning a prestigious SEAL Business Sustainability Award. This honor, received for the second consecutive year, highlights the company’s innovative approach through the launch of the Seamless Infusion...

Continue Reading
Exploring Bonduelle's Monthly Share and Voting Rights Status

Updated Category News Views 131

Understanding Bonduelle’s Monthly Share and Voting Rights Update Bonduelle, a prominent name in the agri-food sector, is renowned for its commitment to quality and sustainable practices. This article provides a detailed overview of the company's monthly insights regarding shares and voting rights. Such transparency is crucial for investors and stakeholders who follow...

Continue Reading